Progesterone transforms the uterine lining from a growing tissue into one that can support a pregnancy. After ovulation, progesterone levels rise from below 1 ng/mL to as high as 25 ng/mL, and this surge drives a complete shift in what the endometrium looks like and how it functions. If no pregnancy occurs, falling progesterone levels trigger the breakdown of the lining and menstruation.
Stopping Growth and Starting Secretion
During the first half of the menstrual cycle, estrogen drives rapid cell division in the endometrial lining, thickening it to roughly 12 to 13 millimeters. Once ovulation occurs and progesterone takes over, that proliferation halts. Progesterone directly opposes estrogen’s growth signals in the surface cells of the endometrium, effectively putting the brakes on further thickening. This shift from growth to maturation is what separates the “proliferative phase” from the “secretory phase” of the cycle.
With proliferation shut down, the endometrial glands begin actively secreting nutrients. Progesterone triggers glycogen (stored sugar) to be packaged and transported to the tips of gland cells, where it’s released into the uterine cavity along with other nutritive substances. These secretions create a rich fluid that can nourish a newly arrived embryo in the days before a placenta forms. By the time the lining reaches its peak thickness of 16 to 18 millimeters before a period, it has been thoroughly reshaped by progesterone into a nutrient-producing tissue.
Decidualization: Preparing for Implantation
The most dramatic change progesterone triggers is called decidualization. This is the transformation of the connective tissue cells (stromal cells) deep in the lining from thin, elongated shapes into plump, rounded cells packed with new proteins. The process starts during the mid-secretory phase, about a week after ovulation, and begins around the spiral arteries in the upper two-thirds of the endometrium. It happens whether or not an embryo is present.
Decidualized cells do several important things. They remodel the tissue’s structural framework, adjust the local immune environment so the body doesn’t reject an embryo, produce growth factors that support early development, and help mature the blood vessel network. Without this transformation, an embryo cannot successfully implant. Progesterone activates its receptor inside these stromal cells, which then switches on a network of genes that coordinate the entire process. When researchers expose stromal cells to progesterone in the lab for about 12 days, the cells undergo this same morphological shift and begin producing the signature proteins of decidualization.
Building a Blood Supply
A well-nourished pregnancy requires a robust blood supply, and progesterone helps build one. During the secretory phase, progesterone (along with estrogen) promotes the development of spiral arteries, the small, coiled blood vessels unique to the uterine lining. It does this by boosting production of growth factors that stimulate new blood vessel formation. These spiral arteries coil tightly through the upper layers of the endometrium and will eventually supply blood to the placenta if pregnancy occurs.
The coiling pattern matters. Spiral arteries are designed to be remodeled further during early pregnancy, when cells from the developing placenta invade their walls and widen them to increase blood flow. Progesterone’s role in getting these arteries established during every cycle is part of the groundwork that makes successful implantation possible.
What Happens When Progesterone Drops
If no embryo implants, the corpus luteum (the structure on the ovary that produces progesterone after ovulation) breaks down, and progesterone levels fall sharply. This withdrawal sets off a precise chain of events in the endometrium.
First, the drop in progesterone releases a brake on inflammatory signaling. Cells in the lining begin producing prostaglandins, which are potent constrictors of blood vessels. At the same time, an enzyme that normally breaks down prostaglandins becomes less active, so prostaglandin levels climb quickly. The result is constriction of the spiral arteries, cutting off blood flow to the upper layers of the endometrium.
Simultaneously, inflammatory signals attract white blood cells into the tissue. These immune cells, along with the stromal cells themselves, release enzymes capable of breaking down the tissue’s structural framework. The endometrium shrinks and compacts within the first day. By days two and three, the upper half of the lining fragments and begins to slough. By day four, most of the functional layer has shed. The deeper basal layer remains intact and will regenerate the lining in the next cycle under estrogen’s influence.
When the Endometrium Doesn’t Respond
In some conditions, the endometrium becomes partially resistant to progesterone’s effects. This is best documented in endometriosis, where both the misplaced tissue and the normal uterine lining show reduced responsiveness to progesterone signaling. The result is that progesterone’s usual anti-proliferative and decidualizing effects are blunted, which can contribute to pain, abnormal bleeding, and difficulty with implantation.
Up to one-third of women with symptomatic endometriosis do not respond adequately to progestin-based treatments, which is thought to reflect this underlying resistance. The problem appears to involve disrupted receptor signaling and altered gene networks that normally carry out progesterone’s instructions. This resistance helps explain why endometriosis can be so difficult to manage and why it frequently coexists with fertility challenges. Ongoing loss of progesterone’s protective, anti-growth effect also allows continued estrogen-driven proliferation, which fuels the disease.